Kaempferol targets estrogen‑related receptor α and suppresses the angiogenesis of human retinal endothelial cells under high glucose conditions

Wu,Yan; Zhang,Qinmei; Zhang,Rui

doi:10.3892/etm.2017.5261

Kaempferol targets estrogen‑related receptor α and suppresses the angiogenesis of human retinal endothelial cells under high glucose conditions

Authors:
- Yan Wu
- Qinmei Zhang
- Rui Zhang
View Affiliations

Affiliations: Department of Endocrinology, The Second Clinical College of Jinan University, Shenzhen Peoples' Hospital, Shenzhen, Guangdong 518020, P.R. China
Published online on: October 3, 2017 https://doi.org/10.3892/etm.2017.5261
Pages: 5576-5582

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Diabetic retinopathy (DR) is the most common complication of diabetes and a major cause of new‑onset blindness in the developed world. The present study aimed to examine the effect of kaempferol on high glucose‑induced human retinal endothelial cells (HRECs) in vitro. The expression levels of various mRNAs and proteins were measured by reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) and western blotting, respectively. The target of kaempferol was determined using a luciferase reporter assay. In addition, HREC proliferation, migration and cell sprouting were determined using Cell Counting kit‑8, wound scratch and tube formation assays, respectively. RT‑qPCR and western blotting results showed that treatment with 30 mM glucose for 12, 24 and 48 h increased the expression level of estrogen‑related receptor α (ERRα) mRNA and protein. The luciferase reporter assay demonstrated that kaempferol inhibited ERRα activity in HRECs. Compared with 5 mM normal glucose treatment, high (30 mM) glucose significantly promoted the proliferation, migration and tube formation of HRECs, which was antagonized by 10 and 30 µM kaempferol in a dose‑dependent manner. Treatment with 30 mM glucose also increased the expression of vascular endothelial growth factor (VEGF) mRNA and protein, and the expression levels of VEGF mRNA and protein were suppressed by kaempferol (10 and 30 µM). Kaempferol (30 µM) treatment also increased the expression levels of thrombospondin 1 (TSP‑1) and a disintegrin and metalloproteinase with thrombospondin motifs 1 (ADAMTS‑1) mRNA; however, TSP‑1 and ADAMTS‑1 levels did not differ between high glucose and normal (5 mM) glucose conditions. The results of this study suggest that kaempferol targets ERRα and suppresses the angiogenesis of HRECs under high glucose conditions. Kaempferol may be a potential drug for use in controlling the progression of DR; however, in vivo studies are required to evaluate its efficacy and safety.

View Figures

View References

1	Yu DY, Cringle SJ, Su EN, Yu PK, Jerums G and Cooper ME: Pathogenesis and intervention strategies in diabetic retinopathy. Clin Exp Ophthalmol. 29:164–166. 2001. View Article : Google Scholar : PubMed/NCBI
2	Hendrick AM, Gibson MV and Kulshreshtha A: Diabetic Retinopathy. Prim Care. 42:451–464. 2015. View Article : Google Scholar : PubMed/NCBI
3	Wan TT, Li XF, Sun YM, Li YB and Su Y: Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy. Biomed Pharmacother. 74:145–147. 2015. View Article : Google Scholar : PubMed/NCBI
4	Osaadon P, Fagan XJ, Lifshitz T and Levy J: A review of anti-VEGF agents for proliferative diabetic retinopathy. Eye (Lond). 28:510–520. 2014. View Article : Google Scholar : PubMed/NCBI
5	Yoo SY and Kwon SM: Angiogenesis and its therapeutic opportunities. Mediators Inflamm. 2013:1271702013. View Article : Google Scholar : PubMed/NCBI
6	Distler JH, Hirth A, Kurowska-Stolarska M, Gay RE, Gay S and Distler O: Angiogenic and angiostatic factors in the molecular control of angiogenesis. Q J Nucl Med. 47:149–161. 2003.PubMed/NCBI
7	Sorenson CM, Wang S, Gendron R, Paradis H and Sheibani N: Thrombospondin-1 deficiency exacerbates the pathogenesis of diabetic retinopathy. J Diabetes Metab. Suppl 12:2013.PubMed/NCBI
8	Basile DP, Fredrich K, Chelladurai B, Leonard EC and Parrish AR: Renal ischemia reperfusion inhibits VEGF expression and induces ADAMTS-1, a novel VEGF inhibitor. Am J Physiol Renal Physiol. 294:F928–F936. 2008. View Article : Google Scholar : PubMed/NCBI
9	Ranhotra HS: The estrogen-related receptor alpha: The oldest, yet an energetic orphan with robust biological functions. J Recept Signal Transduct Res. 30:193–205. 2010. View Article : Google Scholar : PubMed/NCBI
10	Zhang K, Lu J, Mori T, Smith-Powell L, Synold TW, Chen S and Wen W: Baicalin increases VEGF expression and angiogenesis by activating the ERR{alpha}/PGC-1{alpha} pathway. Cardiovasc Res. 89:426–435. 2011. View Article : Google Scholar : PubMed/NCBI
11	Olszewska MA: New validated high-performance liquid chromatographic method for simultaneous analysis of ten flavonoid aglycones in plant extracts using a C18 fused-core column and acetonitrile-tetrahydrofuran gradient. J Sep Sci. 35:2174–2183. 2012. View Article : Google Scholar : PubMed/NCBI
12	Chen AY and Chen YC: A review of the dietary flavonoid, kaempferol on human health and cancer chemoprevention. Food Chem. 138:2099–2107. 2013. View Article : Google Scholar : PubMed/NCBI
13	Kim SH and Choi KC: Anti-cancer effect and underlying mechanism (s) of kaempferol, a phytoestrogen, on the regulation of apoptosis in diverse cancer cell models. Toxicol Res. 29:229–234. 2013. View Article : Google Scholar : PubMed/NCBI
14	Wang J, Fang F, Huang Z, Wang Y and Wong C: Kaempferol is an estrogen-related receptor alpha and gamma inverse agonist. FEBS Lett. 583:643–647. 2009. View Article : Google Scholar : PubMed/NCBI
15	Luo H, Rankin GO, Juliano N, Jiang BH and Chen YC: Kaempferol inhibits VEGF expression and in vitro angiogenesis through a novel ERK-NFκB-cMyc-p21 pathway. Food Chem. 130:321–328. 2012. View Article : Google Scholar : PubMed/NCBI
16	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
17	Dagher Z, Park YS, Asnaghi V, Hoehn T, Gerhardinger C and Lorenzi M: Studies of rat and human retinas predict a role for the polyol pathway in human diabetic retinopathy. Diabetes. 53:2404–2411. 2004. View Article : Google Scholar : PubMed/NCBI
18	Yuan L, Hu J, Luo Y, Liu Q, Li T, Parish CR, Freeman C, Zhu X, Ma W, Hu X, et al: Upregulation of heparanase in high-glucose-treated endothelial cells promotes endothelial cell migration and proliferation and correlates with Akt and extracellular-signal-regulated kinase phosphorylation. Mol Vis. 18:1684–1695. 2012.PubMed/NCBI
19	Chen X, Li J, Li M, Zeng M, Li T, Xiao W, Li J, Wu Q, Ke X, Luo D, et al: KH902 suppresses high glucose-induced migration and sprouting of human retinal endothelial cells by blocking VEGF and PIGF. Diabetes Obes Metab. 15:224–233. 2013. View Article : Google Scholar : PubMed/NCBI
20	Chen Z, Liu G, Xiao Y and Lu P: Adrenomedullin22-52 suppresses high-glucose-induced migration, proliferation, and tube formation of human retinal endothelial cells. Mol Vis. 20:259–269. 2014.PubMed/NCBI
21	Hayashi JN, Ito H, Kanayasu T, Asuwa N, Morita I, Ishii T and Murota S: Effects of glucose on migration, proliferation and tube formation by vascular endothelial cells. Virchows Arch B Cell Pathol Incl Mol Pathol. 60:245–252. 1991. View Article : Google Scholar : PubMed/NCBI
22	Premanand C, Rema M, Sameer MZ, Sujatha M and Balasubramanyam M: Effect of curcumin on proliferation of human retinal endothelial cells under in vitro conditions. Invest Ophthalmol Vis Sci. 47:2179–2184. 2006. View Article : Google Scholar : PubMed/NCBI
23	Zou C, Yu S, Xu Z, Wu D, Ng CF, Yao X, Yew DT, Vanacker JM and Chan FL: ERRalpha augments HIF-1 signalling by directly interacting with HIF-1α in normoxic and hypoxic prostate cancer cells. J Pathol. 233:61–73. 2014. View Article : Google Scholar : PubMed/NCBI
24	Arany Z, Foo SY, Ma Y, Ruas JL, Bommi-Reddy A, Girnun G, Cooper M, Laznik D, Chinsomboon J, Rangwala SM, et al: HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha. Nature. 451:1008–1012. 2008. View Article : Google Scholar : PubMed/NCBI
25	Cao D, Zhou H, Zhao J, Jin L, Yu W, Yan H, Hu Y and Guo T: PGC-1α integrates glucose metabolism and angiogenesis in multiple myeloma cells by regulating VEGF and GLUT-4. Oncol Rep. 31:1205–1210. 2014. View Article : Google Scholar : PubMed/NCBI
26	Liang F, Han Y, Gao H, Xin S, Chen S, Wang N, Qin W, Zhong H, Lin S, Yao X and Li S: Kaempferol identified by zebrafish assay and fine fractionations strategy from dysosma versipellis inhibits angiogenesis through VEGF and FGF pathways. Sci Rep. 5:144682015. View Article : Google Scholar : PubMed/NCBI
27	Betts-Obregon BS, Vellanki S, Buikema J, Tsin AT and Wright K: Effect of glucose on retinal endothelial cell viability and VEGF secretion. HSOA J Cell Biol Cell Metabol. 3:pii: 008. 2016.PubMed/NCBI
28	DiPietro LA, Nebgen DR and Polverini PJ: Downregulation of endothelial cell thrombospondin 1 enhances in vitro angiogenesis. J Vasc Res. 31:178–185. 1994. View Article : Google Scholar : PubMed/NCBI
29	Sun Y, Huang J and Yang Z: The roles of ADAMTS in angiogenesis and cancer. Tumour Biol. 36:4039–4051. 2015. View Article : Google Scholar : PubMed/NCBI
30	Lee NV, Sato M, Annis DS, Loo JA, Wu L, Mosher DF and Iruela-Arispe ML: ADAMTS1 mediates the release of antiangiogenic polypeptides from TSP1 and 2. EMBO J. 25:5270–5283. 2006. View Article : Google Scholar : PubMed/NCBI
31	Krampert M, Kuenzle S, Thai SN, Lee N, Iruela-Arispe ML and Werner S: ADAMTS1 proteinase is up-regulated in wounded skin and regulates migration of fibroblasts and endothelial cells. J Biol Chem. 280:23844–23852. 2005. View Article : Google Scholar : PubMed/NCBI